Ambamustine HCl

TargetMol
Product Code: TAR-T2507L
Supplier: TargetMol
CodeSizePrice
TAR-T2507L-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2507L-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
Ambamustine HCl is a novel tripeptide anticancer.
CAS:
83996-50-3
Molecular Weight:
666.08
Purity:
0.98
SMILES:
N(CCCl)(CCCl)C1=CC(C[C@@H](C(N[C@H](C(OCC)=O)CCSC)=O)NC([C@H](CC2=CC=C(F)C=C2)N)=O)=CC=C1.Cl

References

Ambamustine. PTT119. Drugs R D. 2003;4(2):119-21. PubMed PMID: 12718568. Manna A, Porcellini A, Visani G, Marchetti-Rossi MT, Tura S. Limiting dilution analysis of a novel tripeptide anticancer agent Ambamustine (PTT-119): effect on K-562, CCRF-SB and multidrug resistant LoVo-Dk cell lines. Exp Hematol. 1994 Jun;22(6):517-20. PubMed PMID: 8187848. Mattii L, Barale R, Petrini M. Use of the comet test in the evaluation of multidrug resistance of human cell lines. Leukemia. 1998 Apr;12(4):627-32. PubMed PMID: 9557624. Ardizzoni A, Antonelli G, Ricci S, Frasci G, Rinaldi M, Boni L, Galletti P, Pennucci MC, Antonuzzo A, Gravina A, Galli L, Comella G, Conte PF, Salvati F, Rosso R. Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study. Am J Clin Oncol. 2000 Feb;23(1):22-5. PubMed PMID: 10683068.